Target lesion response predicts survival of patients with hepatocellular carcinoma retreated with transarterial chemoembolization
Target lesion response predicts survival of patients with hepatocellular carcinoma retreated with transarterial chemoembolization
复制标题
靶病灶反应可预测经动脉化疗栓塞治疗的肝细胞癌患者的生存率
DOI:
10.1111/liv.13149
复制
发表时间:
2016-10
影响因子:
6.7
通讯作者:
Shi, Ming
中科院分区:
文献类型:
--
作者:
Tan, Guo-Sheng;Le, Yong;Wei, Wei;Shi, Ming
The discontinuation rules of transarterial chemoembolization (TACE) for patients who were assessed as progressive disease (PD) but stage progression‐free (SP‐free: still belongs to Barcelona Clinic Liver Cancer B) after TACE are unclear. We aimed to evalu
登录
查看更多内容
影响因子:
25.7
作者:
Kim, Beom Kyung;Kim, Seung Up;Han, Kwang-Hyub
通讯作者:
Han, Kwang-Hyub
影响因子:
11.5
作者:
Kim, Beom Kyung;Kim, Seung Up;Chon, Chae Yoon
通讯作者:
Chon, Chae Yoon
DOI:
--
发表时间:
2000
期刊:
Journal of the National Cancer Institute
影响因子:
--
作者:
P. Therasse;S. Arbuck;E. Eisenhauer;J. Wanders;R. Kaplan;L. Rubinstein;J. Verweij;M. V. Van Glabbeke-M.-V.-Van-G
通讯作者:
P. Therasse;S. Arbuck;E. Eisenhauer;J. Wanders;R. Kaplan;L. Rubinstein;J. Verweij;M. V. Van Glabbeke-M.-V.-Van-G
影响因子:
8.4
作者:
通讯作者:
--
影响因子:
3.5
作者:
Arizumi, Tadaaki;Ueshima, Kazuomi;Kudo, Masatoshi
通讯作者:
Kudo, Masatoshi